High costs of orphan drugs: Patients pay the price for policy hurdles in India 0 24.06.2024 11:08 Economictimes.indiatimes.com India manufactures APIs for over 400 FDA-approved orphan drugs, but patients face high costs due to Indian pharma companies' reluctance to develop these drugs domestically. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
